DAPAGLIFLOZIN | A211582 | ZYDUS PHARMACEUTICALS USA INC
1:2018cv00664
2022-07-28
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.